Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01800500 · ClinicalTrials.gov registry record · NA

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

A NA study, sponsored by Roswell Park Cancer Institute.

Terminated
Registry status
NA
Development phase
72
Enrollment target

NCT01800500 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01800500, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.

TERMINATED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

This randomized clinical trial studies interest in smokeless tobacco product as a substitution for cigarettes in current smokers. Use of smokeless tobacco products may help people stop smoking. Measuring use of other sources of nicotine for cigarettes under a variety of different conditions may help determine whether and how much smokers are willing to use substitutions

Interventions

  • OTHER laboratory biomarker analysis
  • OTHER questionnaire administration
  • OTHER quality-of-life assessment
  • BEHAVIORAL smoking cessation intervention

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2011-09
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT01800500

The ClinicalTrials.gov registry entry for NCT01800500 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.

NCT01800500 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01800500 about?

NCT01800500 is a clinical study titled "Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers". This randomized clinical trial studies interest in smokeless tobacco product as a substitution for cigarettes in current smokers. Use of smokeless tobacco products may help people stop smoking. Measuring use of other sources of nicotine for cigarettes under a variety of different conditions may help...

What is the current status of trial NCT01800500?

This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2011-09.

What interventions are being tested in trial NCT01800500?

The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), quality-of-life assessment (OTHER), smoking cessation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01800500?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.